33 results about "Mutational hotspot" patented technology

The invention discloses a kit for one-time qualitative screening of common fourteen mutational sites of deaf gene of Chinese populations and a use method thereof. The kit takes total fourteen sites of the deaf gene of the Chinese populations as detection objects. Application primers and extension primers are respectively designed for the mutation of each site, multiple PCR amplification and markup extension are simultaneously carried out on each target zone, and genotypes of above fourteen sites can be obtained at once through capillary electrophoretic analysis. The screening method and the kit of the invention have advantages of convenient use, simple operation, low cost, high flux, and direct and reliable detection result, and are suitable for large scale screening of the deaf gene mutation of the Chinese populations.

The invention discloses a fluorescent detection kit for detecting 12 deafness predisposing genes simultaneously. The kit can detect 12 mutational hotspots in the most common deafness associated genes of the Chinese in 3 hours. The kit comprises reagents before amplification and reagents after amplification, wherein the reagents before amplification comprise a polymerase chain reaction (PCR) buffer solution, a reaction mixture of MgCl2 and deoxyribonucleoside triphosphates (DNTPs), Taq DNA polymerase, ultrapure water, and a primer mixture for amplifying loci of detection sites at high specificity; and the reagents after amplification comprise a genotyping standard and an internal standard. Deafness gene loci are simultaneously detected at high sensitivity and high specificity by combining a fluorescent labeling technology, a linolenic acid (LNA) nucleoside monomer doping-primer modification technology and a capillary electrophoresis technology for the first time, manpower and material resources and time are greatly saved, and pollution due to multi-step operation is prevented.

The invention relates to a method and kit for detecting BRAF (Block Repeat Active Flag) mutation relevant to the curative effect of a molecular-targeting anti-cancer medicament, in particular relating to a fluorescence quantificational PCR (Polymerase Chain Reaction) detecting method and kit for detecting mutation in BRAF gene mutation hot spot regions and application thereof. According to the invention, mutation at special positions of BRAF genes is detected, the curative effect of the molecular-targeting anti-cancer medicament such as an EGFR (Epidermal Growth Factor Receptor) tyrosine kinase inhibitor, and the like can be forecasted, and furthermore, the individual medicament use schemes of patients with tumors are directed.

The invention discloses a kit for one-time qualitative screening of common seven mutational sites of deaf gene of Chinese populations, and a use method thereof. Seven mutational hotspots which comprise delC of a 235th site of GJB2 gene, delAT of 299-300th sites of the GJB2 gene, A-G mutation of a 2168th site of SLC26A4 gene, A-G mutation of an IVS7-2th site of the SLC26A4 gene, A-G mutation of a 1555th site of mitochondrial DNA gene, A-G mutation of a 3243th site of the mitochondrial DNA gene, and A-G mutation of a 7445th site of the mitochondrial DNA gene are treated as detection objects, application primers and extension primers are respectively designed for the mutation of each site, multiple PCR amplification and markup extension are simultaneously carried out on each target site, and genotypes of above seven sites can be obtained at once through capillary electrophoretic analysis. The screening method and the kit of the invention have advantages of convenient use, simple operation, low cost, high flux, and direct and reliable detection result, and are suitable for large scale screening of the deaf gene mutation of the Chinese populations.

The invention relates to a kit for quantitative detection of K-ras mutation. The invention specifically relates to a detecting method and a detecting kit for K-ras gene mutation relevant with the curative effect of molecular targeted anti-cancer drugs. The invention especially relates to fluorescence quantification PCR detecting method for K-ras gene mutational hotspot region detecting mutational, kit and the application of the fluorescence quantification PCR detecting method. The method of the invention detects the mutation of K-ras gene at a particular locus, predicts the curative effect of molecule targeting anticancer medicament EGFR tyrosine kinases inhibitor, furthermore provides clinic individualized medication scheme for a tumour patient with guidance.

The invention discloses a fluorescent detection kit for detecting 12 deafness predisposing genes simultaneously. The kit can detect 12 mutational hotspots in the most common deafness associated genes of the Chinese in 3 hours. The kit comprises reagents before amplification and reagents after amplification, wherein the reagents before amplification comprise a polymerase chain reaction (PCR) buffer solution, a reaction mixture of MgCl2 and deoxyribonucleoside triphosphates (DNTPs), Taq DNA polymerase, ultrapure water, and a primer mixture for amplifying loci of detection sites at high specificity; and the reagents after amplification comprise a genotyping standard and an internal standard. Deafness gene loci are simultaneously detected at high sensitivity and high specificity by combining a fluorescent labeling technology, a linolenic acid (LNA) nucleoside monomer doping-primer modification technology and a capillary electrophoresis technology for the first time, manpower and material resources and time are greatly saved, and pollution due to multi-step operation is prevented.

The invention provides a lung cancer or colorectal cancer mutant gene detection primer composition. The composition comprises 103 pairs of primers or a combination containing a part of the primers, and the forward primer sequence and the reverse primer sequence of each pair of primers comprise an amplification primer pair and other sequences connected to the 5' end of the amplification primer pair. Specific sequences in a forward primer and a reverse primer of each pair of primers are selected from sequences shown in SEQ ID NO.1-206, and preferably, the specific sequences are 18-25 base sequences in the sequences. According to the composition, 22 mutation hot spot regions of lung cancer or colorectal cancer related genes are carefully selected, a low-initial-quantity or low-quality FFPE sample can be detected, a ctDNA sample can also be detected, and general requirements of early screening, diagnosis, medication and prognosis of lung cancer and colorectal cancer are met.

The invention belongs to the technical field of nucleic acid detection, and particularly relates to a kit for detecting thalassaemia gene mutations. The kit includes amplification primers shown as SEQID NO:1-SEQ ID NO:10 and extension primers shown as SEQ ID NO:11-SEQ ID NO:28. The kit realizes the genotyping of various types of mutation hotspots of thalassaemia genes in the same reaction system,has both flexibility and scalability, is simple in operation and high in throughput and low in cost, and is of great significance for the screening, prenatal diagnosis and the like on people with thalassaemia.

The functional interpretation of somatic mutations remains a persistent challenge in the interpretation of human genome data. Systems and methods for detecting significantly mutated regions (SMRs) in the human genome permit the discovery and identification of multi-scale cancer-driving mutational hotspot clusters. Systems and methods of SMR detection reveal differentially mutated genetic regions across various cancer types. SMR detection and annotation reveals a diverse spectrum of functional elements in the genome, including at least single amino acids, compete coding exons and protein domains, microRNAs, transcription factor binding sites, splice sites, and untranslated regions. Systems and methods of SMR detection optionally including protein structure mapping uncover recurrent somatic alterations within proteins. Systems and methods of SMR detection optionally including differential expression analysis reveal previously unappreciated connections between recurrent and somatic mutations and molecular signatures.

The invention relates to a detection method and kit for detecting U2AF1 gene mutation based on drop-offddPCR. The primers and probes are designed according to the U2AF1 gene DNA sequence, and two wild One is located on the mutation hotspot, and the other is located outside the mutation hotspot. When there are insertions, substitutions, deletions and other mutations in the mutation hotspot, the wild-type probe located at the mutation hotspot cannot tightly bind to the template, so the kit is only used for Two pairs of primer probes can detect multiple mutations in the two mutation hotspots of U2AF1 gene Q157 and S34, and its sensitivity is high, which can be used for MRD monitoring.

Disclosed herein are therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use.

The invention discloses a novel chromosome microdeletion / microduplication syndrome detection system which mainly comprises 643 pairs of probes, multiplex PCR (polymerase chain reaction) amplification primers and correlation detection reaction reagents. The detection process comprises the following steps: hybridizing a probe set with target nucleic acid in the sample; connecting the hybridized probe; amplifying the connecting probe; and detecting the amplification product to determine the existence or quantity of the target nucleic acid in the sample. The platform can implement systematic screening and detection on 24 chromosome aneuploids, 24 chromosome telomere abnormities, more than 70 chromosome microdeletion / microduplication syndromes and multiple monogenic disease mutation hot spots at one time by using the optimized probe set and reaction system. Compared with the existing like detection techniques (such as MLPA and the like), the detection system covers nearly all definite pathogenic regions with abnormal number of copies in the DECIPHER database, has the advantages of wide detection range, high detection precision and low cost, and is simple to operate.

The invention belongs to the field of protein engineering, in particular to a PET hydrolase mutant. The technical problem to be solved by the present invention is that the activity of the PET hydrolase (PETase) currently derived from the Ideonella sakaiensis 201-F6 strain is not ideal. The technical solution of the present invention to solve the technical problem is to provide a PET hydrolase mutant. In the present invention, 5 mutation hotspots are obtained through a large number of researches on PET hydrolase (PETase); 14 mutants are constructed by applying site-directed mutation technology, and the activity of 2 mutant ETase enzymes is finally screened out compared with the wild type Ec_PETase. , has a good application prospect.

The invention relates to a gene mutation detection kit for human glucose-6-phosphate dehydrogenase deficiency, which comprises probes with sequences shown in SEQ NO.1-382. The present invention analyzes the distribution of 500 G6PD gene positive mutation sites in China, and combines the human gene mutation database (Human Gene Mutation Database, HGMD) database and gene mutation hotspot data in Europe and the United States to more comprehensively summarize the G6PD gene mutation hotspots, To solve the genetic mutation detection problem of nearly 99% of patients with G6PD deficiency, and realize the rapid and effective genetic diagnosis of G6PD deficiency disease.

The present invention relates to a β-catenin oligonucleotide microchip for detecting mutation in the mutational hot spot regions of β-catenin gene, a manufacturing process thereof and a method for detecting the β-catenin mutation employing same, wherein specific oligonucleotides are selectively designed to detect various missense mutations and in-frame deletion at the mutational hot spots of β-catenin gene. The β-catenin oligo chip of the present invention can be used in studies to detect β-catenin mutations and unravel the signal transduction mechanism and tumorigenesis related to β-catenin gene.

The invention is applicable to the technical field of gene engineering, and provides a glioma mutant gene detection primer composition, a kit and application of the kit. The primer composition comprises 242 pairs of primers or a combination comprising part of the primers, and specific sequences in a forward primer and a reverse primer of each pair of primers are selected from sequences shown as SEQ ID NO.1-484. The specific sequences in the forward primer and the reverse primer of each pair of primers are 18-25 base sequences in the sequence. A forward primer of the amplification primer pair comprises a sequence as shown in SEQ ID NO. 485. A reverse primer of the amplification primer pair comprises a sequence as shown in SEQ ID NO. 486. According to the invention, a plurality of authoritative databases are combined, mutation hot spot regions of 13 glioma related genes and conserved regions of 1p and 19q chromosomes are selected, a low-initial-quantity or low-quality FFPE sample can be detected, a cerebrospinal fluid sample can also be detected, and general requirements of diagnosis, medication and prognosis of glioma are met. And the comparison rate, the target rate and the uniformity of amplicons are relatively good.